Neo Ivy Capital Management’s Eli Lilly LLY Stock Holding History

Neo Ivy Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-168	Closed	-$79K	–	393
2023 Q2	$79K	Buy	+168	New	+$70.5K	0.04%	242
2022 Q4	$722K	Buy	+1,974	New	+$700K	0.49%	80
2022 Q3	–	Sell	-265	Closed	-$85K	–	469
2022 Q2	$85K	Buy	+265	New	+$79.5K	0.23%	163
2021 Q4	–	Sell	-3,292	Closed	-$540K	–	544
2021 Q3	$540K	Buy	3,292 +3,267	+13,068%	+$806K	0.62%	37
2021 Q2	$6K	Sell	25 -687	-96%	-$138K	0.01%	406
2021 Q1	$133K	Buy	+712	New	+$139K	0.15%	210
2020 Q4	–	Sell	-1,739	Closed	-$257K	–	508
2020 Q3	$257K	Sell	1,739 -1,553	-47%	-$240K	0.26%	140
2020 Q2	$540K	Buy	3,292 +3,196	+3,329%	+$491K	0.62%	37
2020 Q1	$13K	Buy	+96	New	+$13.2K	0.02%	410
2019 Q3	–	Sell	-13,062	Closed	-$1.45M	–	347
2019 Q2	$1.45M	Buy	+13,062	New	+$1.54M	0.82%	7

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Neo Ivy Capital Management's LLY Position: Q3 2023 in Review

Neo Ivy Capital Management sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 168 shares — an estimated $79K sold.

Neo Ivy Capital Management first reported a position in LLY in Q2 2019 and held it in 10 quarters. The position peaked at $1.45M in Q2 2019. 2,975 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

Neo Ivy Capital Management reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
Neo Ivy Capital Management sold 168 Eli Lilly shares in Q3 2023, an estimated $79K.
Neo Ivy Capital Management first reported a position in Eli Lilly in Q2 2019 and held it in 10 quarters.
Neo Ivy Capital Management's Eli Lilly position peaked at $1.45M in Q2 2019.
2,975 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Neo Ivy Capital Management's 13F filing for Q3 2023, filed 30 Nov 2023.